BioDelivery Sciences International, Inc. (BDSI) News
StocksNews Articles for BDSI
|Loading, please wait...|
Latest BDSI News From Around the Web
Below are the latest news stories about Biodelivery Sciences International Inc that investors may wish to consider to help them evaluate BDSI as an investment opportunity.
BioDelivery Sciences to Present Three Scientific Posters Comparing BELBUCA® to Oxycodone at the 2021 North American Neuromodulation Society (NANS) Meeting
Oral Presentation of Data from Phase I Safety Study & Secondary Respiratory Outcomes Comparing BELBUCA® to Oxycodone on January 16 from 1:10pm – 2:10pm CTRALEIGH, N.C., Jan. 15, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with chronic conditions, will present three scientific posters regarding BELBUCA® (buprenorphine buccal film), CIII at the 2021 North American Neuromodulation Society Meeting (NANS) taking place virtually January 15-16, 2021.“We are pleased to be presenting this data at NANS 2021 and sharing this information with the scientific community,” said Thomas Smith, M.D., Chief Medical Officer of BDSI.Data from a placebo-controlled study compared safety outcom...
Musculoskeletal Pains Market - Insights On Scope 2025 | Zogenix, Inc., Dainippon Sumitomo Pharma Co., Ltd., BioDelivery Sciences International, Inc.
Global Musculoskeletal Pains Market: Snapshot Musculoskeletal pain is pain that affects bones, muscles, or the various types of connective tissues that hold the two together, such as tendons and ligaments. This type of pain can occur due to overuse or repetitive
Are Robust Financials Driving The Recent Rally In BioDelivery Sciences International, Inc.'s (NASDAQ:BDSI) Stock?
BioDelivery Sciences International's (NASDAQ:BDSI) stock is up by a considerable 15% over the past three months. Given...
BioDelivery Sciences International, Inc. (NASDAQ:BDSI) insider James Vollins sold 20,320 shares of the firm’s stock in a transaction that occurred on Monday, December 14th. The shares were sold at an average price of $4.46, for a total transaction of $90,627.20. Following the transaction, the insider now owns 20,320 shares in the company, valued at approximately […]
The biotechnology industry includes companies that develop drugs and diagnostic compounds for the treatment of diseases and medical conditions. These products must go through a rigorous, costly, and time-consuming testing process before potentially obtaining approval from the U.
BioDelivery (BDSI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
RALEIGH, N.C., Nov. 20, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical…
BioDelivery Sciences to Present Virtually and Host 1x1 Investor Meetings at the Annual Southwest IDEAS Investor Conference on November 18
RALEIGH, N.C., Nov. 11, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that Jeffrey Bailey, Chief Executive Officer, and Terry Coelho, Chief Financial Officer, will participate in the virtual Southwest IDEAS Investor Conference on November 18, 2020. BDSI’s presentation will be webcasted and is scheduled to be available at 7:00 am CST on November 18. The presentation can be accessed through the Southwest IDEAS conference portal for registered participants, in the investor relations section of the Company's website: www.bdsi.com, and on the IDEAS conference website: www.IDEASconferences.com. About IDEAS Investor Co...
BioDelivery Sciences International, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year
It's been a good week for BioDelivery Sciences International, Inc. (NASDAQ:BDSI) shareholders, because the company has...
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...